Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ceftazidime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental ceftazidime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional ceftazidime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af ceftazidim, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Ceftizoxime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental ceftizoxime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional ceftizoxime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af ceftizoxim, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Cefixime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental cefixime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional cefixime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af cefixim, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Cefodizime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental cefodizime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional cefodizime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af cefodizim, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Cefpodoxime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental cefpodoxime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional cefpodoxime overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af cefpodoxim, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Ceftriaxone overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental ceftriaxone overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional ceftriaxone overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af ceftriaxon, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Ceftibuten overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental ceftibuten overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional ceftibuten overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af ceftibuten, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Cefsulodin overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental cefsulodin overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional cefsulodin overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af cefsulodin, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Fourth generation cephalosporin overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Cefpirome overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental cefpirome overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional cefpirome overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af cefpirom, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af stof tilhørende gruppen af tetracycliner |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Doxycycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental doxycycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional doxycycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af doxycyclin, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Minocycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental minocycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional minocycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af minocyclin, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Oxytetracycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental oxytetracycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional oxytetracycline overdose (disorder) |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af oxytetracyclin, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Tetracycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental tetracycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional tetracycline overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af tetracyclin, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Chloramphenicol overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Accidental chloramphenicol overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
Intentional chloramphenicol overdose |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af chloramphenicol, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af co-trimoxazol |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
accidentel overdosis af co-trimoxazol |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
tilsigtet overdosis af co-trimoxazol |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
overdosis af co-trimoxazol, uvist med hvilken hensigt |
Causative agent |
False |
Baktericid |
Inferred relationship |
Some |
|
pakning med clarithromycin 500 mg tablet og lansoprazol kapsel 30 mg og amoxyllin kapsel 500 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Sulfasalazine 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Sulfasalazine 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
sulfasalazin 3 g/100 ml retentionsklysma |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
tobramycin 300 mg/5 ml inhalationsvæske til nebulisator, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
penicillinasefølsomme penicilliner |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely benzylpenicillin sodium 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Benzylpenicillin sodium 600 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing benethamine penicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing benzathine benzylpenicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 25 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
floxacillin 250 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
floxacillin 500 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 25 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin (as flucloxacillin sodium) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely flucloxacillin (as flucloxacillin magnesium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
bredspektrede penicilliner |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Amoxicillin 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
amoxicillin + clavulanatkalium 125 mg/31 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
amoxicillin + clavulanatkalium 400 mg/57 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
co-amoxiclav 250 mg + 125 mg sukkerfri dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
co-amoxiclav 250 mg/62 mg/5 ml sukkerfri suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely ampicillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Baktericid |
Inferred relationship |
Some |
|